“showed a trend”

Pooled analysis of 11 studies involving 818 participants in the prevention cohort showed a trend toward reduction in the need for RRT in the ANP group (OR 0.45; 95% CI 0.21–0.99; P =0.05).

Analysis of our data did not reveal a statistically significant association between physical or mental multimorbidity and rates of irreversible organ damage (SDI ≥ 1), although the total number of physical comorbidities showed a trend for correlation with the SDI (Spearman’s rho = 0.126, p = 0.050).

While HIU-pretreated FTGase showed a trend towards lower solubility compared to untreated FTGase, this difference was not statistically significant ( P > 0.05).

RT-qPCR analysis showed a trend for increased miR-141 expression and decreased FOXC1 expression in HGC27 cells in response to si-LINC00242 transfection ( p < 0.05) (Fig. 3 k).

Conversely, D -Fructose concentrations showed a trend towards higher levels in the glucose-loaded group compared to the non-loaded group ( p = 0.05) (Fig. 3B ).

However, DP UPF only showed a trend of inhibition of LPS induced TNF-α with 10% inhibition ( p < 0.05) at 100 μg/mL concentration ( Figure 3 B).

Pairwise comparisons showed a trend for a difference between medicated individuals with ADHD and those with MDD ( P =.05; d =0.72; MDiff=11.63, 95% CI –0.08 to 23.34).

We failed to identify significant differences in the APRs expression according to the use of treatment. Associations between acute phase reactants gene expression and their plasma concentrations Plasma CRP showed a trend toward higher levels in COPD patients (4.4±1.73 mg/mL) than in control group (3.8±2.04 mg/mL, P >0.05).

In P-types, fasting propionate concentrations were higher after AX compared with INU ( P = 0.04) and showed a trend compared with PLA ( P = 0.05, Figure 2 B).

Multiple comparison results indicated that MCE supplementation significantly increased HDL-C concentration ( p < 0.01) and showed a trend toward lower LDL-C in the S1 group ( p < 0.05).

In anterior lumbar roots ( Figures 3 C, 3D, 3G, and 3H), the ratio of abnormally myelinated fibers reached 0.25 ± 0.01 (n = 11) in mock compared to 0.15 ± 0.02 in treated mice (n = 11; p = 0.0002; Figure 3 K), while the numbers of foamy macrophages showed a trend for decrease in treated (9.18 ± 1.66; n = 11) compared to the mock-treated mice (13.35 ± 1.21; n = 11; p > 0.05; Figure 3 L).

The FC of HHP-pretreated RBPH showed a trend of first increasing and then decreasing with the increase in pressure, and the HHP pretreatment at 200 MPa produced the highest FC ( p < 0.05).

We observed that FS application showed a trend towards reducing the ankylosis compared to the control group without reaching statistically different levels (p > 0.05) (Table 1 ; Fig. 2 ).

64%, P = 0.048) and showed a trend towards lower prevalence of anti‐heart auto‐antibodies positivity at diagnosis as compared with patients not receiving follow‐up EMB (47% vs. 71%, P = 0.05).

28 , 29 While ATG clearly decreased the risk of acute GvHD, the adjusted model showed a trend towards improved overall survival in patients who received ATG ( P =0.05).

HFD showed a trend toward increased oxidative DNA damage ( p > 0.05) and mitochondrial DNA copy number ( p < 0.05) compared with controls.

Eyes with ERSS ≥4 showed higher TBI and a trend to higher CBI ( p =0.051) and eyes with BCRClasik ≥8 showed a trend to higher TBI values ( p =0.050).

The visual component showed a trend difference between groups over time during processing of angry faces ( U = 51.00, z = − 1.94, p = 0.05).

In addition, capsule wall thickness showed a trend to increase with time after implantation in the Resilon groups ( P < 0.05), opposed to the significant decrease ( P = 0.016) observed after implantation in the gutta-percha groups, suggesting lesser long-term biocompatibility of Resilon.

Microglial depletion caused a slight, but not significant, decrease in GFAP intensity in wild-type mice, and PLX-treated ATXN1[82Q] mice showed a trend toward a decrease in GFAP expression (Fig. 4b , one-way ANOVA, p > 0.05).

Patients undergoing PT showed a trend toward a more favorable outcome compared to those not receiving treatment, although this difference did not reach statistical significance (CGI-C 2 vs. 3, p = 0.050) ( Figure 3 ).

When treated with a ten-fold higher dose of ETH, MOX or PZA, a significant reduction in SAMTB lux bioluminescence was observed for MOX (x10) at all timepoints (with P < 0.0001 by 96 h post-infection); while ETH (x10) showed a trend in the reduction of SAMTB lux bioluminescence, with significant reduction at 96 h post-treatment (p < 0.05) when compared to the control ( Figure 9 ).

Though it did not reach statistical significance (p = 0.05), p38α ΔNeu mice showed a trend towards more thigmotaxis, i.e. movement restricted to the periphery of the open field arena (Fig. 1H ).

Non-hematological disorders showed a trend toward a better OS (77.9 vs. 62.9%; p = 0.05).

Analysis of the fluorescence intensity showed similar Iba1 intensities in most of the retinal layers between the Gne+/− and Gne+/+ WT mice at 9 and 12 months of age, except for the INL, which showed a trend for an increased Iba1 intensity in Gne+/− mice at 12 months ( p = .050).